Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-07-19
2005-07-19
Foley, Shanon (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S186100, C424S204100, C514S002600, C514S04400A, C435S005000, C435S006120, C435S007100, C435S320100, C435S325000
Reexamination Certificate
active
06919083
ABSTRACT:
The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce an immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences, is herein described.
REFERENCES:
patent: 6471964 (2002-10-01), Biering et al.
patent: WO/ 00/72878 (2000-12-01), None
patent: WO 01/49712 (2001-01-01), None
patent: WO 01/66569 (2001-09-01), None
patent: WO/ 02/26784 (2002-04-01), None
Ritchie et al. Virus Genes. 2001; 22 (3): 289-297.
Clouthier et al., Genomic organization of infectious salmon anaemia virus. Journal of General Virology 83, 421-428, 2002.
Fields et al., Eds., Fields Virology, Third Edition. Lippincott Williams & Wilkins, Philadelphia, 1996, p. 1356.
Krossoy B. et al.: “The putative polymerase sequence of infectious salmon anemia virus suggests a new genus within theOrthomyxoviridae” Journal of Virology, (Mar. 1999) 73 (3) 2136-42, XP000986368.
Kibenge et al. “Antigenic VarIation Among Isolates of Infectios Salmon Anaemia Virus Correlates with Genetic Variation of the Viral Haemagglutinin Gene”, Journal of General Virology, vol. 82, pp. 2869-2879, (2001).
Krossoy et al. “Cloning and Identification fo the infectious Salmon Anaemia Virus Haemagglutinin” Journal of General Virology, vol. 82, pp. 1757-1765, (2001).
Rimstad et al. “Characterization of the Infectious Salmon Anemia Virus Genomic Segment that Encodes the Putative Hemagglutinin”, Journal of Virology, vol. 75, No. 11, pp. 5352-5356, (2001).
Griffiths et al., “Characterization of ISAV Proteins from Cell Culture”, Diseases of Aquatic Organisms, vol. 45, pp. 19-24, (2001).
Mjaaland et al. “Genomic Charcterization of the Virus Causing Infectious Salmon Anemia in Atlalntic Salmon (Salmo salarL.): an Orthomyxo-Like Virus in Teleost”, Journal of Virology, vol. 71, No. 10, pp7681-7686, (1997).
Falk et al., Characterization of Infectious Salmon Anenia Virus, an Orthomyxo-Like Virus Isolated from Atlantic Salmon (Salmo salarL.) Journal of Virology, vol. 71, No. 12, pp. 9016-9023, (1997).
Griffiths Steven
Heppell Joel
Ritchie Rachel Jane
Foley Shanon
Marks David L.
Novartis AG
Ottawa Health Research Institute
LandOfFree
Nucleic acid and amino acid sequences of infectious salmon... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and amino acid sequences of infectious salmon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and amino acid sequences of infectious salmon... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3385303